Published guidance, NICE advice and quality standards | Guidance

Showing 31 to 40 of 2013

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	26 January 2016	26 January 2016
Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor	TA195	25 August 2010	25 August 2010
Adefovir dipivoxil and peginterferon alfa-2a for the treatment of chronic hepatitis B	TA96	22 February 2006	22 February 2006
Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: the DYSIS colposcope with DYSISmap and the ZedScan I	HTG467	25 April 2018	25 April 2018
Adrenal insufficiency: identification and management	NG243	28 August 2024	28 August 2024
Advanced breast cancer: diagnosis and treatment	CG81	23 February 2009	19 February 2025
Advocacy services for adults with health and social care needs	NG227	9 November 2022	9 November 2022
Afamelanotide for treating erythropoietic protoporphyria	HST27	26 July 2023	26 July 2023
Afatinib for treating advanced squamous non-small-cell lung cancer after platinum-based chemotherapy (terminated appraisal)	TA444	24 May 2017	24 May 2017
Afatinib for treating epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell lung cancer	TA310	23 April 2014	23 April 2014